Loading company…
Riskpilot
← Back to search
Sign in
Get full access
NG2X Pharma ApS
APS
Active
CVR 46229355
Vermehrensvej 8
Research and experimental development on natural sciences and engineering · NACE 7210
Est. 2026
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue
—
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit
—
EBITDA — year on year
DKK millions
0M
-0M
-1M
-1M
-1M
Key figures
Annual report
Revenue
—
—
EBITDA
—
—
Net profit
—
—
Total assets
—
—
Equity
—
—
Employees
—
—
Company information
Legal name
NG2X Pharma ApS
CVR number
46229355
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
29. januar 2026
Share capital
DKK 20.000
Employees
—
VAT registered
Yes
Audit selected
No
Last report
—
Financial year
January – December
Signatory rights
Selskabet tegnes af en direktør.
Company purpose
Selskabets formål er udvikling af lægemidler samt salg af rettighederne til disse til andre virksomheder, samt aktiviteter i tilknytning hertil.
Contact
Address
Vermehrensvej 8
Phone
+4525135309
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Research and experimental development on natural sciences and engineering
Companies in Ringsted
All Denmark companies
Revenue
DKK millions
EBITDA
DKK millions
Income statement
DKK thousands
Item
Revenue
Staff expenses
EBITDA
Depreciation & amort.
EBIT
Net financials
Profit before tax
Tax
Net profit
Balance sheet
DKK thousands
Item
Total assets
Equity
Long-term debt
Short-term debt
Total debt
Financial ratios
5-year trend
EBITDA margin
%
This company
15.8%
Market median
-NaN% vs market
Equity ratio
%
This company
38.2%
Market median
-NaN% vs market
Return on equity
%
This company
18.4%
Market median
-NaN% vs market
Net profit margin
%
This company
8.1%
Market median
-NaN% vs market
Asset turnover
×
This company
1.12×
Market median
-NaN% vs market
Debt / equity
×
This company
0.62×
Market median
-NaN% vs market
Annual reports & filings
Management
Actively employed in the business
Name
Role
Member since
Current (1)
ND
Nicolaj Donskov Nielsen
Management
Management
2026
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
VILAS PHARMACEUTICAL SERVICES ApS
Company
100%
100%
2026
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
VILAS PHARMACEUTICAL SERVICES ApS
NG2X Pharma ApS
(this company)
Board network connections
Board members of NG2X Pharma ApS also hold positions in
0
other companies.
Person
Role here
Other companies
Nicolaj Donskov Nielsen
Management
0 companies